Also trades as: LABB.MX (MEX) · $vol 2M
GNMLF OTC
Genomma Lab Internacional, S.A.B. de C.V.
1W: -1.3%
1M: -6.3%
3M: -12.8%
YTD: -31.2%
1Y: -37.6%
3Y: -2.3%
5Y: -8.8%
$0.73
+0.04 (+6.51%)
Weekly Expected Move ±6.6%
$1
$1
$1
$1
$1
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.3B
+19.8% ▲
5Y CAGR: +4.3%
Total Liabilities
$706M
+21.3% ▲
5Y CAGR: +2.4%
Shareholders Equity
$616M
-94.7% ▼
5Y CAGR: +6.8%
Cash & Investments
$159M
-93.3% ▼
5Y CAGR: +8.5%
Total Debt
$425M
+36.4% ▲
5Y CAGR: +5.5%
Net Debt
$266M
-93.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $62M | $77M | $1.5B | $2.4B | $159M |
| Short-Term Investments | $0 | $0 | $183M | $0 | $0 |
| Cash & ST Investments | $62M | $77M | $1.7B | $2.4B | $159M |
| Net Receivables | $1.2B | $347M | $225M | $4.6B | $397M |
| Inventory | $107M | $123M | $1.9B | $2.2B | $135M |
| Other Current Assets | $7.2B | $0 | $6.3B | $2.0B | $12M |
| Total Current Assets | $561M | $580M | $10.7B | $12.1B | $712M |
| Property, Plant & Equip. | $164M | $184M | $3.4B | $3.6B | $216M |
| Goodwill & Intangibles | $5.2B | $5.2B | $5.0B | $289M | $323M |
| Long-Term Investments | $37M | $40M | $43M | -$733M | $8M |
| Other Non-Current Assets | -$4.9B | -$4.9B | $1.0B | $6.9B | $9M |
| Total Non-Current Assets | $488M | $528M | $10.1B | $11.0B | $610M |
| Total Assets | $1.0B | $1.1B | $1.2B | $1.1B | $1.3B |
| — Liabilities — | |||||
| Accounts Payable | $1.4B | $1.8B | $108M | $1.7B | $88M |
| Short-Term Debt | $2.1B | $4.8B | $2.0B | $65M | $157M |
| Deferred Revenue | $21M | $14M | $921K | $0 | $0 |
| Other Current Liabilities | -$5.4B | $781M | $931M | $2.9B | $116M |
| Total Current Liabilities | $320M | $480M | $6.6B | $6.5B | $401M |
| Long-Term Debt | $187M | $80M | $4.2B | $243M | $266M |
| Other Non-Current Liab. | $24M | $6M | $114M | $530M | $4M |
| Total Non-Current Liabilities | $239M | $108M | $4.7B | $5.6B | $305M |
| Total Liabilities | $559M | $587M | $664M | $582M | $706M |
| — Equity — | |||||
| Common Stock | $93M | $98M | $1.9B | $1.8B | $101M |
| Retained Earnings | $459M | $515M | $638M | $11.5B | $660M |
| Accumulated OCI | -$6M | -$7M | $0 | $0 | -$48M |
| Total Stockholders Equity | $490M | $521M | $552M | $11.6B | $616M |
| Total Liabilities & Equity | $1.0B | $1.1B | $1.2B | $1.1B | $1.3B |
| — Key Metrics — | |||||
| Total Debt | $290M | $330M | $6.2B | $311M | $425M |
| Net Debt | $229M | $253M | $4.8B | $4.2B | $266M |
| Total Investments | $37M | $40M | $42M | $89M | $8M |